Jun '16

Dr. Marc Dauer Appointed as New Advisor

Dr. Dauer’s  input will assist in assessing the potential our biosynthetic scaffold has for hair restoration.  

Read Article ›
Apr '16

New Partnership with Winthrop-University Hospital

New collaboration with Winthrop-University Hospital for research and validation of our technology.

Read Article ›
Feb '16

Gemstone Bio Featured in Baltimore Business Journal

Our newly licensed tech from Johns Hopkins sparked the interest of the BBJ about our growth and potential to help millions in need.

Read Article ›
Feb '16

Newly Licensed Tech Holds Major Wound Healing Potential

New technology we’ve recently licensed from Johns Hopkins has the potential to provide older,  diabetic patients with chronic wounds a treatment option superior to current products.

Read Article ›
Nov '15

Our Views on Tech Transfer Featured in The Baltimore Sun

We’re thrilled to share our views on the ways a well-established biotechnology tech transfer initiative can bolster Baltimore’s economy. 

Read Article ›
Oct '15

Gemstone Bio Continues To Expand Team

We’re thrilled to announce the addition of two new team members. Dr. David Abramson joins the Gemstone Bio Advisory Team and Dr. Ian Tolfree joins Gemstone Bio’s Leadership Team as director of operations.

Read Article ›
Sep '15

Industry Veteran Geoff MacKay Joins Board of Directors

Geoff MacKay is an expert in the regenerative medicine industry. His leadership in growing bio-tech companies is invaluable to us as we plot our growth strategy.

Read Article ›
Jul '15

Latest study of our product published in The Journal of Investigative Dermatology

The results suggest that the dextran hydrogel may substantially enhance healing quality and improve the care and outcomes for patients with severe burn injuries.

Read Article ›
Jul '15

Gemstone Biotherapeutics Study Shows Superior Regenerative Wound Healing Response

New study results show 3rd degree wounds treated with our product achieved complete re-epithelialization and nerve ingrowth. The regenerated skin demonstrated characteristics of uninjured skin. This affirms the superior wound healing performance of our biosynthetic scaffold technology.

Read Article ›
Jun '15

Johns Hopkins Announces Gemstone Bio’s Selection as Best Life Sciences Company for 2015

Johns Hopkins University announced today that Gemstone Biotherapeutics’ award confirms the efficacy of FastForward in fostering young companies and bringing new technologies to the marketplace.

Read Article ›


“[The] findings could yield more effective treatments for patients afflicted with burns, diabetic complications and other conditions in which vasculature function is compromised.”
– Sharon Gerecht, Ph.D.